In focus · trending topic

Clinical Trial Data

1 stories · following the connections

Clinical Cancer Research Publishes Phase I Data from a Study of Rafael Pharmaceuticals' Lead CPI-613 Compound in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

By Nasdaq OMXApr 12, 2018, 3:00 PM UTC